Clinical Trial Update: Cyclophosphamide Plus Topotecan in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 clinical trial evaluating cyclophosphamide plus topotecan in patients with refractory or relapsed acute myeloi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Topotecan (topotecan)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Leukemia | Phase 2 | Status: COMPLETED